Delivery Order SPE2DB24D1205-SPE2DB25FCZYU
- Not listed
- The Defense Logistics Agency awarded a $9,100.35 delivery order to AmerisourceBergen Drug Corp for VISCOAT syringes (0.5mL) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that runs through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Viscoat Syringes (0.5 mL), valued at $3,087.53. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.75 to AmerisourceBergen Drug Corp for 0.5mL Viscoat syringes, with an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office based in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.75ML) under a firm fixed-price contract valued at $21,916.13. The order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,853.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viscoat syringes (0.5ml) valued at $27,117.66. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will take place at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Viscoat syringes (0.75ml) with a ceiling value of $7,439.20. This firm fixed-price delivery order is set to be completed by September 24, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating competitive selection among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,640.14 to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) under a firm fixed-price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was not set aside for small businesses and was competitively awarded. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Viscoat Syringes (0.5 mL) under a firm fixed-price contract valued at $3,452.31. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,426.76 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Viscoat syringes (0.5 mL). This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract requires completion by September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZYUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VISCOAT syringes (0.5ml) valued at $3,483.35 under a firm fixed-price contract type. The award, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, vaccines, syringes, and related medical commodities across multiple therapeutic domains. The firm fixed-price delivery order structure and competitive award process reflect the company's established capacity to meet federal procurement requirements and support military medical supply chain needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/27/25 |